#Breaking New federal guidance recommends childhood vaccines for 11 diseases downsizing immunization protection from the previous list of 18 diseases. #IDsky #Medsky www.contagionlive.com/view/us-comp...

A delay in providing standard infant vaccinations is associated with children not receiving MMR (measles, mumps, rubella) vaccine by 2 years of age.

[email protected] discusses the series of politically driven actions, including defunding mRNA research, dismantling vaccine advisory bodies, and restricting CDC recommendations, that have undermined vaccine access, but professional societies, states are stepping in to preserve public health.

Read about increasing influenza activity, an approach to de-escalating empiric broad spectrum antibiotics for clinically stable patients with community-onset sepsis, and more.

Jill Morgan, RN, BSN, talks about steps being taken to ensure everyone’s safety is front of mind. #IDsky #Medsky

CDC surveillance shows sharp week-over-week increases in influenza test positivity, outpatient illness, and hospital admissions, with A(H3N2) continuing to predominate nationwide. #IDsky #Medsky

Jill Morgan, RN, BSN, reviews this significant part of clinical care and how personal protective equipment (PPE) is essential to protecting healthcare workers. #IDsky #medsky

The recent CDC ACIP meetings and subsequent actions show a path for which the current Health and Human Services department wants to roll back access to vaccines for this virus and other vaccines. #IDsky #Medsky

Emory's Gavin Harris, MD, discusses these elements, and how despite the fact they rarely occur, the need to do continuous training is essential for readiness. #IDsky #Medsky

Shortening course of empiric broad spectrum antibiotics for community-onset sepsis was associated with fewer days of antibiotics and hospitalization and no increase in mortality. #IDsky #Medsky

This week, check out our Media Day coverage from Emory, the WHO report on malaria, and more. #IDsky #Medsky www.contagionlive.com/view/top-inf...

In the final installment of the series, psychiatrist Robert C Bransfield, MD, outlines how interdisciplinary research, education, and policy could help reduce infection-associated neuropsychiatric impairment and violence.

In the second installment of this 2-part article on the WHO 2025 World Malaria Report, the authors point out the positive trends in the scaling up of prevention efforts with new-generation anti-mosquito netting, vaccines and periodic chemoprevention. www.contagionlive.com/view/who-fin...

The WHO 2025 World Malaria Report adds several countries to those certified as malaria free, while recognizing spread of antimalarial drug resistance.

Amy Colson, MD, MPH, discusses phase 2 data showing durable virologic suppression, low resistance risk, and favorable safety with weekly oral islatravir plus lenacapavir in suppressed adults with HIV.

Dr. Gavin Harris discusses his experience working in outbreak environments where there is high-consequence infectious disease and how it is important to establish buy-in from the local populations and some of the important elements of what you need to leave behind when an outbreak is declared over.

Agreement supports commercialization and reimbursement efforts for tobevibart plus elebsiran as the ECLIPSE clinical program advances, including completion of enrollment for the ECLIPSE 3 trial.

#ICYMI: The Fall/Winter issue is out! Read further about lenacapavir's role in PrEP, the 2025 CLSI Subcommittee recommendations for antimicrobial susceptibility testing, an update on non–carbapenemase-producing carbapenem-resistant Enterobacterales, and more. www.contagionlive.com/view/contagi...

The single-source award will fund a large randomized trial evaluating mortality, morbidity, and developmental outcomes following the hepatitis B birth dose, amid ongoing debate over non-specific vaccine effects.

Our Fall/Winter issue is out! Read the latest in infectious disease including lenacapavir's role in PrEP, the 2025 CLSI Subcommittee recommendations for antimicrobial susceptibility testing, and more. Check out the issue here: www.contagionlive.com/view/contagi...

This week, learn more about Emory's approach around treating high-consequence infectious diseases such as Ebola, a UNC researcher's work in sequencing syphilis genomes in the search to develop a global vaccine, how the US is in danger of losing its elimination status for measles, and more.

Emory's Gavin Harris, MD, talks about taking care of patients with high-consequence infectious diseases, and working with other healthcare facilities around COVID-19 care and educating them through Emory's ECHO program on new and existing threats.

Zandraetta Tims-Cook, MD, MPH, AAHIVS, discusses access challenges, missed-dose management, and scalable care models for cabotegravir PrEP in women.

CDC reports over 1,900 confirmed cases and 49 outbreaks nationwide, with recent surges reported in South Carolina, Utah, Arizona, and Connecticut amid declining childhood vaccination coverage. www.contagionlive.com/view/us-meas...

Jonathan Parr, MD, MPH, discusses his work in locating potential targets to develop a syphilis vaccine and the challenges associated with genomic diversity of subpopulations of the main pathogen, Treponema pallidum. #IDsky #Medsky

A Nature Microbiology study shows that structure-guided bile acid design can lock Clostridioides difficile toxin B into an inactive conformation.

This new recommendation relates to infants born to women who test negative for hepatitis B. This is a departure from the federal agency’s previous recommendation and comes on the heels of the ACIP’s recent meeting. #IDsky #Medsky

Andrew Handel, MD, talks about transmission, differential diagnosis, treatment, and protection against it. #IDsky #Medsky

An impending deadline is coming up in early 2026. However, this can be reversible and unnecessary infections, severe disease, and deaths can be avoided. Dr. Rodney Rohde talks about incidence rates, how we got here, and strategies to increase immunizations. #IDsky #Medsky

Margaret Aldrich, MD, provides insight around this concept, addressing stewardship within this patient population, and how their institution’s collaborative work environment helps all of the department’s clinicians. www.contagionlive.com/view/caring-...

Gilead Sciences reported positive phase 3 ARTISTRY-2 results demonstrating that a once-daily single-tablet combination of bictegravir and lenacapavir is statistically noninferior to bictegravir/emtricitabine/tenofovir alafenamide tablets in virologically suppressed adults with HIV. #IDsky #Medsky

Innoviva CMO David Altarac, MD, offers further insights about the newly-approved antibiotic and its potential place in the market. #IDsky #medsky www.contagionlive.com/view/zoliflo...

This week, check out our coverage on 2 antibiotic FDA approvals, and clinicians weigh in on the ACIP recommendations on the hepatitis B virus (HBV) vaccine. #IDsky #Medsky www.contagionlive.com/view/top-inf...

#Breaking The antibiotic's approval was based from phase 3 results demonstrating noninferiority to a combination therapy. #IDsky #Medsky

Infectious disease pediatrician sharon nachman MD, talks about how the new recommendations will defer immunization, leading to negative impacts on long-term public health. www.contagionlive.com/view/a-pedia...

Excited to share our latest publication about SEP-1 metrics during the BCx shortage in the setting of enhanced BCx stewardship efforts @kcawcutt.bsky.social @ichejournal.bsky.social #IDSky www.cambridge.org/core/journal...

GSK’s David Payne, PhD, provides more information are the data from the EAGLE-1 trial. #IDsky #medsky

#Breaking The federal nod was given based from the phase 3 data of the EAGLE-1 trial, which showed noninferiority to combination therapy. This approval provides a new oral option. www.contagionlive.com/view/fda-app...

NYU’s Angelica Cifuentes Kottkamp, MD, FIDSA, MD, continues our Media Day discussion around these illnesses, and how in New York City, clinicians need to be prepared to decipher in differential diagnosis for these potential diseases. #IDsky #Medsky www.contagionlive.com/view/working...

Reports are surfacing the federal agency is going to review products already reviewed and approved. www.contagionlive.com/view/fda-pla...

In episode 2 of our Media Day series with New York University (NYU), Angelica Cifuentes Kottkamp, MD, discusses its vaccine center and their work around COVID-19 vaccines, as well as the importance of achieving diversity in clinical trials. #IDsky #Medsky

Robert Hopkins, Jr, MD, medical director of the @nfidvaccines.bsky.social discusses the changes around the new vaccine recommendations and what potential serious consequences may be seen as a result. #IDsky #Medsky

The federal agency approved Augmentin XR in just 2 months through the new CNPV pilot program, marking a major step toward rebuilding domestic antibiotic manufacturing and addressing longstanding the country's drug shortages. #IDsky #Medsky

Questions raised about unverified FDA claims linking COVID-19 vaccines to pediatric deaths, and concerns that proposed vaccine testing requirements could delay access to key immunizations. #IDsky #Medsky

A large meta-analysis indicates opioid exposure may disrupt immunity and gut microbiota, increasing CDI vulnerability and potentially worsening clinical outcomes. #IDsky #Medsky

Our Media Day series is back and we are featuring New York University. For the first episode, Angelica Cifuentes Kottkamp, MD, discusses how its location, breadth of experience, and opportunities afford clinicians the ability to see and treat a wide berth of diseases and infections.

Most clinical isolates identified as triazole-resistant Aspergillus niger by traditional clinical laboratory methods were revealed by DNA sequencing to be A tubingensis. #IDsky #Medsky

Population study corroborates 2019 FDA alert based on case reports of acute respiratory failure with TMP-SMX in healthy adolescents and young adults. #IDsky #Medsky

Read our coverage on the CDC ACIP meetings on the hepatitis B virus (HBV) vaccine, modeling data on the potential consequences of HBV infections, liver cancer, and mortality when delaying the birth dose to 2 months, our latest podcast, and more. www.contagionlive.com/view/top-inf...

#Breaking Lacking any safety data showing potential serious adverse effects, the committee decided to move forward with the recommendation “that the initial dose administered no earlier than 2 months of age.” www.contagionlive.com/view/acip-vo...